Search
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 2 of 2 items.
Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant
… Sotrovimab for Injection - Risk of Treatment Failure due to … risk communication See Key Messages below 2022-04-14 Sotrovimab, 500 mg IV Sotrovimab, 500 mg IV, is unlikely to maintain efficacy …
AlertHealth professional risk communication | 2022-04-14
Authorization of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic
… Authorization of Sotrovimab for Injection for Use in Relation to the COVID-19 … of medicine in hospitals. Key messages On July 30, 2021, sotrovimab for injection, a monoclonal antibody, was … and Advertising of Drugs for Use in Relation to COVID-19 . Sotrovimab is indicated for the treatment of mild to moderate …
AlertHealth professional risk communication | 2021-10-04